Chikungunya Cases in New Delhi Have Risen Up to 432, and Dengue Cases to 487

A typical chikungunya patient manifests high-grade fever, severe joint pain, headache, muscle pain, joint swelling, or rash.

In order to prevent chikungunya from spreading, people should not allow water stagnation, protect themselves from mosquito bites, keep the surroundings clean, dispose off unnecessary items such as old tyres, flower pots, cans, etc., use mosquito repellents or mosquito net, and keep their bodies well covered, say officials.

Chikungunya - Causes, Symptoms, Diagnosis, Treatment. FAQs
Chikungunya is a viral disease spread by mosquito bites; it causes fever, severe joint pain and rash on the body. Chikungunya occurs in Africa, Asia and the Indian sub continent.

‘Chikungunya cases have risen to 432 and dengue cases to 487 cases and two deaths in New Delhi til August 27, 2016.’

Tweet it Now

Chikungunya cases have risen to 432 and dengue cases to 487 cases and two deaths in New Delhi til August 27, 2016, reported the three civic corporations.

According to the municipal corporations, the highest number of dengue cases have been witnessed in the areas under the North Delhi Municipal Corporation with the figure standing at 97. In the East Delhi Municipal Corporation area, there are 15 cases, and the South Delhi Municipal Corporation has seen 71 cases.

All India Institute of Medical Sciences (AIIMS) alone recorded 391 cases till August 20, 2016.

Chikungunya Cases Highest This Year In India Since 2006
India has witnessed 9,990 suspected cases of the vector-borne chikungunya disease till now, with Karnataka reporting the highest 7,591 cases till July, 2016.

Diagnosing chikungunya entails distinguishing it from dengue, as both diseases being caused by the bite of the same mosquito - Aedes aegypti.

Source-IANS

Cases of Dengue, Chikungunya are Much Higher Than Reported in India
The findings reinforce the need for officials to be on the lookout for dengue and chikungunya cases, and to find ways to control its spread in India.

Antibodies are Being Developed to Defeat Ae.aegypti - the Chikungunya Virus
Using antibodies and body's natural immune defense may be more effective in treating the infection than developing synthetic drug, which has higher failure rate.